Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
But nothing universal yet
Lilly does not promote or encourage the unapproved use of Mounjaro and Zepbound for anyone, including by persons under the age of 18
Acute Gallbladder Disease In a pool of Study 1 and 2, cholelithiasis was reported in 1.1% of ZEPBOUND-treated patients and 1% of placebo-treated patients, cholecystitis was reported in 0.7% of ZEPBOUND-treated patients and 0.2% of placebo-treated patients, and cholecystectomy was reported in 0.2% of ZEPBOUND-treated patients and no placebo-treated patients
What Research Shows About Semaglutide and Muscle Clinical research on GLP-1 medications shows that weight loss can include some lean mass loss, but outcomes vary widely
Placella today to discuss your individual weight management goals and explore if weight loss injections might be a suitable option for you
